A new class of Fe(III) macrocyclic complexes with alcohol donor groups as effective T1 MRI contrast agents.
Early studies suggested that Fe(III) complexes cannot compete with Gd(III) complexes as T1 MRI contrast agents. Here we show that one member of a new class of high spin macrocyclic Fe(III) complexes produces more intense contrast in mice kidneys and liver at 30 minutes post injection than does a commercially used Gd(III) agent and also produces similar T1 relaxivity in serum phantoms at 4.7 T and 37 oC. Comparison of four different Fe(III) macrocyclic complexes elucidates the factors that contribute to relaxivity in vivo including solution speciation. Variable temperature 17O NMR studies suggest that none of the complexes has a single, integral inner-sphere water that exchanges rapidly on the NMR time scale. MRI studies in mice show large in vivo differences of three of the Fe(III) complexes that correspond, in part, to their r1 relaxivity in phantoms. Changes in overall charge of the complex modulate contrast enhancement, especially of the kidneys.